NC State Licenses Supplement Reducing GI Inflammation

By NC State Staff

NC State researchers have created a new probiotic supplement that reduces gastrointestinal inflammation. The supplement was developed by engineering a strain of bacteria, and it’s now licensed and commercially available for purchase.

Rodolphe Barrangou, the Todd R. Klaenhammer Distinguished Professor in Food, Bioprocessing and Nutrition Sciences, led a team of researchers studying the bacterium Lactobacillus acidophilus. A strain of this bacterium, L. acidophilus NCFM, was discovered at NC State in the 1970s and has been studied extensively since. NCFM stands for North Carolina Food Microbiology, the lab where this strain was discovered ...

NC State Science to Supplement: CodonRX Pioneers a New Era in Gut Health

By NC State News

RALEIGH, N.C. — Innovation at NC State University is transforming lives, one scientific breakthrough at a time. The latest success story, CodonRX, a probiotic supplement designed to reduce gastrointestinal inflammation, is already making an impact on digestive health worldwide.

Developed from decades of research at NC State, CodonRX represents a rare achievement: university-patented science evolving into a commercial product that directly improves quality of life ...

Provaxus licenses NC State’s probiotic for reducing GI inflammation

By Stephen Daneills

The new probiotic supplement uses an extensively researched strain engineered to reduce gastrointestinal inflammation, giving the product “a very broad audience”.